Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia.

M, Talpaz; HM, Kantarjian; K, McCredie; JM, Trujillo; MJ, Keating; JU, Gutterman

doi:10.1056/nejm198604243141701

Public

Hematologic remission and cytogenetic improvement induced by recombinant human interferon alpha A in chronic myelogenous leukemia.

Shared by NobleBlocks on Apr 1, 1986 • 12:00 AM UTC

Authors:

Talpaz M

Kantarjian HM

McCredie K

Abstract

We treated 17 patients who had Philadelphia-chromosome-positive chronic myelogenous leukemia (4 of whom had not received therapy and 13 of whom had been treated with hydroxyurea or busulfan for less than six months) with recombinant human interferon alpha A (Roferon-A). The interferon was given as 5...

Discussions